Fayez Sarofim & Co
CELG

Fayez Sarofim & Co’s Celgene Corp CELG Stock Holding History

Fayez Sarofim & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-611,672
Closed -$89.2M – 252
2017
Q3 		$89.2M Sell
611,672
-18,998
-3% -$2.59M 0.47% 49
2017
Q2 		$81.9M Sell
630,670
-53,515
-8% -$6.56M 0.44% 52
2017
Q1 		$85.1M Sell
684,185
-97,962
-13% -$11.7M 0.46% 53
2016
Q4 		$90.5M Sell
782,147
-49,987
-6% -$5.57M 0.5% 52
2016
Q3 		$86.9M Sell
832,134
-28,700
-3% -$3.11M 0.47% 53
2016
Q2 		$85.2M Sell
860,834
-5,017
-0.6% -$519K 0.47% 52
2016
Q1 		$86.8M Sell
865,851
-4,826
-0.6% -$497K 0.5% 50
2015
Q4 		$104M Sell
870,677
-18,874
-2% -$2.18M 0.6% 50
2015
Q3 		$97.2M Buy
889,551
+8,712
+1% +$1.08M 0.56% 53
2015
Q2 		$102M Buy
880,839
+113,102
+15% +$12.9M 0.52% 57
2015
Q1 		$88.4M Sell
767,737
-9,757
-1% -$1.17M 0.43% 62
2014
Q4 		$87.3M Buy
+777,494
New +$82M 0.41% 61

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fayez Sarofim & Co's CELG Position: Q4 2017 in Review

Fayez Sarofim & Co sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 611,672 shares — an estimated $89.2M sold.

Fayez Sarofim & Co first reported a position in CELG in Q4 2014 and held it in 12 quarters. The position peaked at $104M in Q4 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Fayez Sarofim & Co reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Fayez Sarofim & Co sold 611,672 Celgene Corp shares in Q4 2017, an estimated $89.2M.
  • Fayez Sarofim & Co first reported a position in Celgene Corp in Q4 2014 and held it in 12 quarters.
  • Fayez Sarofim & Co's Celgene Corp position peaked at $104M in Q4 2015.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Fayez Sarofim & Co's 13F filing for Q4 2017, filed 13 Feb 2018.